BioSpace News Archive

Joint venture aimed at changing the paradigm in which mental health disorders are treated.

From the Healthcare Industry Report, Black Book Research, 2019

DNAtrix’s oncolytic virus technology will be highlighted across six additional abstracts selected for presentation.

The webcast will be recorded and available for replay on the Company’s website for 14 days.

Today, Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced a collaboration agreement with Siemens Healthineers, a global leader in medical technology, in nonalcoholic steatohepatitis (NASH) and liver fibrosis

The initiative brings private-sector hospice providers together with the federal agency and national organization to promote veteran-centric education and improve high quality of care for veterans.

Lev El Diagnostics of Heart Diseases Ltd. (Lev-El), announced the results of the world’s largest prospective multi-center clinical study to evaluate the correlation between heart rate variability (HRV) and the presence of myocardial ischemia in healthy individuals without known coronary artery disease (CAD) that will be presented at The American Heart Association’s (AHA) 2019 Annual Scientific Sessions

In an elaborate ceremony before approximately 1,500 guests here yesterday, the Inamori Foundation presented its 35th Annual Kyoto Prizes, Japan’s highest private awards for global achievement, in the categories of Advanced Technology, Basic Sciences, and Arts and Philosophy.